Drug manufacturer Merck Serono has announced that it will provide its Pliazon cream for skin reactions to all UK patients undergoing anti-EGFR antibody treatment for metastatic colorectal cancer (mCRC). Pliazon® is a regenerating, moisturising and normalising cream that forms a protective barrier on the skin which shields the skin from external factors that may cause damage. The treatment is available via an order form that is available by emailing CSC.uk@merckserono.net
Merck Serono to provide free Pliazon cream to mCRC patients
Sign in or register for free
Already registered?
Latest from News
• By
• 
A pharmacist has been hailed as “incredible” after she spotted a patient’s leukaemia red flags during an NHS Pharmacy First Plus consultation.
• By
• It assesses whether the next funding contract will support pharmacists, keep patients safe, and offer long-term sustainability.
• By
• Experts have long been calling for pharmacists to be able to conscientiously object to taking part in the assisted dying process, but one researcher argues that pharmacists’ voices are “missing” from this dialogue.
More from Clinical
• By
• The new pharmacy contract has expanded who can deliver the smoking cessation service, as well as adding the provision of two drugs via PGDs.
• By
• The government has announced an expansion to and fresh payment structure for the new medicine service (NMS) to “boost mental health support in the community”.